Literature DB >> 14714402

The interaction of liposomes with the complement system: in vitro and in vivo assays.

Janos Szebeni1, Lajos Baranyi, Sandor Savay, Janos Milosevits, Michael Bodo, Rolf Bunger, Carl R Alving.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14714402     DOI： 10.1016/S0076-6879(03)73010-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  15 in total

1.  Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs.

Authors:  Robert Luxenhofer; Anita Schulz; Caroline Roques; Shu Li; Tatiana K Bronich; Elena V Batrakova; Rainer Jordan; Alexander V Kabanov
Journal:  Biomaterials       Date:  2010-03-26       Impact factor: 12.479

Review 2.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

3.  Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.

Authors:  Okhil K Nag; Vivek R Yadav; Andria Hedrick; Vibhudutta Awasthi
Journal:  Int J Pharm       Date:  2013-02-16       Impact factor: 5.875

4.  Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.

Authors:  Geoffrey Gifford; Vivian P Vu; Nirmal K Banda; V Michael Holers; Guankui Wang; Ernest V Groman; Donald Backos; Robert Scheinman; S Moein Moghimi; Dmitri Simberg
Journal:  J Control Release       Date:  2019-04-08       Impact factor: 9.776

5.  Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population.

Authors:  Halli Benasutti; Guankui Wang; Vivian P Vu; Robert Scheinman; Ernest Groman; Laura Saba; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2017-11-01       Impact factor: 4.774

6.  Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.

Authors:  Yvonne Klapper; Osama A Hamad; Yuji Teramura; Gero Leneweit; G Ulrich Nienhaus; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Biomaterials       Date:  2014-01-23       Impact factor: 12.479

Review 7.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

8.  Biological evaluation of liposome-encapsulated hemoglobin surface-modified with a novel PEGylated nonphospholipid amphiphile.

Authors:  Vivek R Yadav; Okhil Nag; Vibhudutta Awasthi
Journal:  Artif Organs       Date:  2014-04-22       Impact factor: 3.094

Review 9.  Army Liposome Formulation (ALF) family of vaccine adjuvants.

Authors:  Carl R Alving; Kristina K Peachman; Gary R Matyas; Mangala Rao; Zoltan Beck
Journal:  Expert Rev Vaccines       Date:  2020-03-31       Impact factor: 5.217

Review 10.  Hypersensitivity reactions to radiocontrast media: the role of complement activation.

Authors:  Janos Szebeni
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.